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Edited by Jesus AvilaAbstract The transcription factor Pitx3 plays an important
role in the development of midbrain to promote the growth and
diﬀerentiation of dopamine neurons. The present study has dem-
onstrated that overexpression of Pitx3 in SH-SY5Y cells and
primary ventral mesencephalic (VM) cultures signiﬁcantly in-
creased the mRNA levels of brain-derived neurotrophic factor
(BDNF) and glial cell line-derived neurotrophic factor (GDNF),
and remarkably elevated the protein levels of these two neurotro-
phic factors. Our data provide the ﬁrst evidence that pitx3-
expressing cells are able to upregulate the expression of BDNF
and GDNF. Therefore, Pitx3 might be a good target for the
treatment of Parkinson’s disease.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pitx3 is a homeodomain transcription factor and its expres-
sion in brain is highly restricted in the dopamine (DA) neurons
of substantia nigra (SN) and ventral tegmental area (VTA)
[1,2]. It has been reported that Pitx3-deﬁcient aphakia mice
failed to develop nigrostriatal pathway, showing a complete
loss of DA neurons in the SN, while DA neurons in the
VTA were less aﬀected [3–5]. The DA levels in the dorsal stri-
atum in the Pitx3-deﬁcient mice were severely reduced by 84–Abbreviations: AADC, amino acid decarboxylase; BDNF, brain-deri-
ved neurotrophic factor; DA, dopamine; DAT, dopamine transporter;
GDNF, glial cell line-derived neurotrophic factor; RT-PCR, reverse
transcriptase-polymerase chain reaction; SNc, substantia nigra pars
compacta; TH, tyrosine hydroxylase; VM, ventral mesencephalon;
VTA, ventral tegmental area
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doi:10.1016/j.febslet.2007.02.05493% that of wild-type mice [4,6,7]. Mesencephalic DA neurons
and their immediate progenitors can be subdivided into two
partially overlapping groups based on their temporal expres-
sion proﬁles of tyrosine hydroxylase (TH) and Pitx3: the ven-
trolateral mesencephalic cells express Pitx3 prior to TH, whilst
the dorsomedial midbrain DA neurons express TH ahead of
Pitx3 [8]. It is still unknown why the selective loss of DA neu-
rons occurs in Pitx3-deﬁcient mice. We hypothesize that Pitx3
may regulate the expression of genes which are necessary for
DA neuron survival. Here we report that exogenous expression
of Pitx3 in SH-SY5Y cells and primary ventral mesencephalic
(VM) cultures regulates the expression of brain derived neuro-
trophic factor (BDNF) and glial derived neurotrophic factor
(GDNF).2. Materials and methods
2.1. Plasmid construction
PCR products for Pitx3 were ampliﬁed by RT-PCR from mouse
midbrain total mRNA using the RT-PCR system (Promega, USA)
with the following primers: forward 5 0 ACA GCC ACC ACC CGG
AGT 3 0 reverse 5 0 GCA CCC CTT TCA GAC CCT 3 0, and cloned
into pUCm T-vector (Sangon, China). Then Pitx3 cDNA was
subcloned into pcDNA3.1(+) (Invitrogen, USA) and sequenced to
conﬁrm identity with the Pitx3 mRNA sequence in NCBI database
(NM_008852).2.2. Stable transfection and isolation of Pitx3-expressing SH-SY5Y cell
clones
SH-SY5Y cells were grown on poly-D-lysine (Sigma, USA) pre-
coated dishes in Dulbecco’s modiﬁed Eagle’s medium (DMEM, GIB-
CO-Invitrogen, USA) supplemented with 10% fetal bovine serum
(heat-inactivated, GIBCO-Invitrogen). SH-SY5Y cells were trans-
fected with Pitx3-pcDNA3.1 or pcDNA3.1 using lipofectamine 2000
(Invitrogen). Stably transfected cells were selected with 600 lg/ml Neo-
mycin (DUCHEFA, Holand). Neomycin-resistant clones were ex-
panded and total proteins from each clone were collected in RIPA
lysis buﬀer. Clones expressing pitx3 were identiﬁed by Western-blot
analysis using anti-pitx3 antibody (Zymed, USA).2.3. Primary mesencephalic cultures and transfection
Primary embryonic rat (embryonic day 14, E14; Experimental Ani-
mal Center of Shanghai) VM cells were isolated and cultured accord-
ing to the method described previously [9]. VM cells were transfected
with Pitx3-pcDNA3.1 or pcDNA3.1 using lipofectamine2000 after
six days cultured in the serum-free medium, consisting of DMEM/
Ham’s F12 (1:1) with the addition of 2% B27 supplement (Sigma). Pro-
tein or RNA was extracted from VM cells after three days of cultures.blished by Elsevier B.V. All rights reserved.
1358 C. Peng et al. / FEBS Letters 581 (2007) 1357–1361Animal care and procedures were performed in accordance with the
Laboratory Animal Care Guidelines approved by Shanghai Institutes
for Biological Sciences of Chinese Academy of Sciences.
2.4. Immunocytochemistry
Cells were ﬁxed in 4% formaldehyde for 30 min, rinsed with PBS,
and then incubated with blocking buﬀer (PBS, 5% normal horse serum;
Vector Labs, USA) for 30 min. Cells were then incubated overnight at
4 C with rabbit anti-pitx3 antibody (Zymed). After additional rinsing
in PBS, cells were incubated with TRITC-conjugated anti-rabbit anti-
body or biotinylated anti-rabbit IgG (Vectastain Elite ABC kit, Vector
Labs, USA) for 2 h at RT. After rinsing for 3 · 10 min in PBS, cells for
immuno-ﬂuorescent staining were incubated with Hoechst for 5 min
and examined under the ﬂuorescent microscope; cells for diam-
inobenzidine (DAB) staining were incubated with avidin-biotinyla-
ted-peroxidase complex for 1 h (Vectastain Elite ABC kit, Vector
Labs). Immunoreactivity was visualized by DAB substrate (Vector
Labs), and examined under the light microscope.2.5. Semiquantitative RT-PCR analysis
Total RNA from cultured cells was prepared using SV Total RNA
Isolation System (containing DNase I, Promega). For RT-PCR
analysis, 2 lg of RNA was transcribed into cDNA with the Reverse
Transcription System (Promega) and oligo (dT) primers in 20 ll vol-
ume. The cDNA was then analyzed in a PCR assay using the primers
as given in Table 1. PCRs were carried out in 1· reaction buﬀer,
0.2 lM of each primer, 1 ll cDNA and 2.5 units of TaqDNA polymer-
ase (Promega).
2.6. Western-blot analysis
Cells were extracted in ice-cold RIPA lysis buﬀer. Lysates were then
centrifuged for 10 min at 14000 · g at 4 C, 40 lg of protein from each
supernatant was loaded onto 12% SDS–PAGE and transferred to
polyvinylidene diﬂuoride, blocked for 1 h in 5% non-fat milk, and
incubated with primary antibodies [anti-pitx3 (Zymed), anti-b-actin
(Sigma), anti-BDNF (Promega) and anti-GDNF (Promega)]. Incuba-
tions took place overnight at 4 C. After washing 3 · 10 min in TBST,
samples were incubated with peroxidase-conjugated secondary anti-
body for 2 h, then washed in TBST and developed with Super SignalTable 1
Primer
Gene Forward primer
Reverse primer
Pitx3 5 0GAGCACAGTGACTCGGAGAAGG30
5 0AAGGCGAACGGGAAGGTC3 0
GAPDH 5 0CCATGTTCGTCATGGGTGTGAACCA30
5 0GCCAGTAGAGGCAGGGATGATGTTC30
BDNF 5 0AGCGTGAATGGGCCCAAGGCA30
5 0TGTGACCGTCCCGCCCGACA30
GDNF 5 0CTGGGCTATGAAACCAAGGA30
5 0GACAGGTCATCATCAAAGGC30
TrkB 5 0ATGAGTATGGGAAGGATG3 0
5 0ATGCCAAACTTGGAGTGT3 0
Nurr1 5 0GAGTCTGATCAGTGCCCTCGTC30
5 0CTTCCACTCTCTTGGGTTCCTTG30
TH 5 0GCAGTTCTCGCAGGACATTG30
5 0TGGATGCGTGAGGCATAGC3 0
AADC 5 0TTACTCATCCGATCAGGCACAC30
5 0GGCAGAACAGTCAAAATTCACC30
GFRa1 5 0AGACCATCGTGCCTGTGTGCT30
5 0GGTCATGACTGTGCCAATAAG30
NGF 5 0CCACCGCCACAGACATCAAG30
5 0TCGGCAGGTCAGGCTCTTCT30
NGFR 5 0GCCTGAAGTTGGAGTGAGTGT30
5 0AGGTGATAGGAGGGTTGCTG30
BDNF (Rat) 5 0AGCGTGAATGGGCCCAGGGCA30
5 0TGTGACCGTCCCACCGGACA30
GDNF (Rat) 5 0TTGGGCTACGAAACCAAGGA30
5 0GACAGGTCGTCGTCGAAGGC30
GAPDH (Rat) 5 0CCATGTTTGTGATGGGTGTGAACCA30
5 0GCCAGTGGATGCAGGGATGATGTTC30West Dura Extended Duration Substrate (Pierce Biotechnology,
USA). The identiﬁed proteins were quantiﬁed by measuring optical
densities of the bands.
2.7. Measurement of BDNF and GDNF by ELISA
The medium from treated and untreated cell cultures was concen-
trated up to four fold using centrifugal ﬁlter devices (Amicon
Ultra-4 Ultracel-10k, Millipore). The protein concentration of the
samples was adjusted to the same levels before 100 lL of each sample
was applied into each well (Maxisorpa 96-well plate, Nunc) for the
immunoassay. The protein concentration of BDNF and GDNF was
measured using BDNF or GDNF Emax immunoAssay System (Prome-
ga) and the procedures performed per manufacturers’ instruction.3. Results
3.1. Exogenous expression of Pitx3 in nucleus
We constructed the expression vector PcDNA3.1-Pitx3 to
generate Pitx3-overexpressing SH-SY5Y cell clones. Two
clones (P1 and P4) were found to express Pitx3 (upper panel
of Fig. 1). Immunochemical analysis showed that exogenous
expression of Pitx3 was present in the nucleus (mid panel,
Fig. 1C) and pitx3 was not detected in two controls (SHC2,
an empty vector-transfected clone, Fig. 1A and naı¨ve SH-
SY5Y, Fig. 1B). Using immuno-ﬂuorescent staining with
Hoechst we found that Pitx3 was only located in SH-SY5Y cell
nuclei (lower panel, Fig. 1F).
3.2. Overexpression of Pitx3 upregulates mRNA expression of
BDNF and GDNF in SH-SY5Y cells
We hypothesized that Pitx3 may regulate genes that are
important for the development and survival of DA neurons,
such as neurotrophic factors and their receptors. So we ana-
lyzed gene expressions of several neurotrophic factors (i.e.,Length of product (bp) Tm (C) Cycles
413 60 26
251 58 25
363 60 28
173 54 31
298 58 28
437 54 28
321 54 30
385 57 28
215 56 35
295 60 32
401 57 30
369 60 30
173 54 35
251 58 25
Fig. 1. Isolation of SH-SY5Y cell clones expressing Pitx3. Upper panel: Western blot analysis showed that Pitx3 protein was detected in samples of
P1 and P4 clones, whereas none was seen in naı¨ve SH-SY5Y cells (Con lane). Mid panel: immunochemistry analysis of Pitx3. (A) SHC2 cells, an
empty vector-transfected clone; (B) naı¨ve SH-SY5Y cells; (C) Pitx3-expressing SH-SY5Y cells. Lower panel: Immuno-ﬂuorescent staining of Pitx3.
(D) Pitx3-expressing SH-SY5Y cells; (E) Hoechst staining of nuclear; (F) overlay of (D) and (E). Scale bar, 10 lm.
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receptors (i.e., TrkB, GFRa1, NGFR, and FGFR), in addition
of various DA markers (i.e., TH, Nurr1, AADC and DAT), in
the Pitx3-expressing SH-SY5Y cells.
We found that mRNA levels of BDNF and GDNF were 1.7-
and 1.3-fold higher in Pitx3-expressing SH-SY5Y cells than
two controls cells (SHC2, an empty vector-transfected and na-
ı¨ve SH-SY5Y cells), respectively, while their corresponding
receptors TrKb and GFRa1 were downregulated (Fig. 2).
The expression of mRNA of NGF and its receptor was not
obviously changed in Pitx3-expressing SH-SY5Y cells as com-
pared to controls (Fig. 2). The expression of mRNA of FGF
and its receptor FGFR was not detected in all samples after
PCR ampliﬁcation over 45 cycles (Fig. 2). While expressions
of TH, Nurr1, DAT (data not shown), and AADC mRNAs
were not visibly altered by Pitx3 transfection (Fig. 2).
3.3. Upregulation of BDNF and GDNF proteins by transgene
expression of Pitx3
Consistent with the mRNA changes, the proteins of BDNF
and GDNF were increased 10-, 5.9-fold, respectively, in Pitx3-
expressing SH-SY5Y cells as compared with controls (Fig. 3).
ELISA showed that the protein level of BDNF secreted by
Pitx3-expressing SH-SY5Y cells was increased 4.6-fold over
controls (SH-Pitx3, 12.3 ± 0.93 pg/ml, controls, 2.7 ± 0.24 pg/
ml and 2.6 ± 0.22 pg/ml, n = 3, Fig. 3), and the protein level
of GDNF secreted from Pitx3-expressing SH-SY5Y cells was
increased 2.5-fold over controls (SH-Pitx3, 9.1 ± 0.69 pg/ml,
controls, 3.7 ± 0.30 pg/ml and 3.6 ± 0.33 pg/ml, n = 3, Fig. 3).
3.4. Increased expression of BDNF and GDNF by Pitx3
transfection in VM cultures
Pitx3 transfection in primary VM cultures increased mRNA
levels of BDNF and GDNF by 1.4-, 1.5-fold, and upregulatedprotein levels of BDNF and GDNF by 1.9-, 1.7-fold (Fig. 4
right), respectively, as compared with pcDNA3.1-transfected
controls (Fig. 4 left).4. Discussion
BDNF and GDNF are the two most important neurotro-
phic factors for the diﬀerentiation and survival of midbrain
DA neurons [10–12]. In addition, both BDNF and GDNF
can protect DA neurons against neurotoxins in vivo and
in vitro [13–15]. Moreover, BDNF protein produced by mid-
brain DA neurons not only provides a neurotrophic eﬀect on
the DA neurons itself, but it is also transported in a retrograde
manner to aﬀect striatal neurons function [15–17]. GDNF
expression was detectable in the ventral midbrain at embryonic
day (E) 18 and postnatal day one and continued to present at
substantia nigra pars compacta (SNc) and VTA neurons in
adult rodents [18–20]. Moreover, expression of the GDNF
receptor complex, GFRa1 and Ret, was detectable in SNc
region by E10, before striatal innervation [21]. These ﬁndings
support the notion that GDNF promotes DA neurons survival
and diﬀerentiation in an autocrine and/or paracrine fashion in
the developing and adult midbrain.
Our study demonstrated for the ﬁrst time that Pitx3 can
upregulate the expression of these two neurotrophic factors
in SH-SY5Y cells as well as in primary VM cultures at both
transcriptional and translational levels. In this study, we also
found that TrkB and GFRa1, the neurotrophic factor recep-
tors of BDNF and GDNF, respectively, were downregulated
in the Pitx3-expressing SH-SY5Y cells, presumably through
the negative feedback regulation responding to the dramatic
increase of the ligands BDNF and GDNF. It is yet to deter-
mine in the future study the molecular mechanisms by which
Fig. 2. Semiquantitative RT-PCR analysis of mRNA diﬀerences
between Pitx3-expressing SH-SY5Y and controls (SHC2 and Con,
naive SH-SY5Y). RNA samples were prepared from Pitx3-expressing
clones P1 and P4. For comparisons, we used SHC2 cells (an empty
vector-transfected clone) and naı¨ve SH-SY5Y cells.
Fig. 3. Upregulation of protein levels of BDNF and GDNF in Pitx3-
expressing SH-SY5Y. Upper panel: Tested by Western blot analysis,
protein levels of BDNF and GDNF increased 10- and 5.9- fold in
Pitx3-expressing SH-SY5Y cells, respectively, when compared with
controls (SHC2 cells and Con, naı¨ve SH-SY5Y cells). b-Actin served as
an internal control. Lower panel: increase of BDNF and GDNF
proteins secreted by Pitx3-expressing SH-SY5Y cells. The content of
BDNF and GDNF released into the culture medium (pg/ml) was
measured by ELISA. Data shown are means ± S.E.M. values from
three independent experiments performed in triplicate. Data analysis
were performed by using one-way ANOVA followed by post hoc S-N-
K multiple comparisons with the SPSS 13.0 program (SPSS). A P-
value of <0.05 was considered signiﬁcant (**,P < 0.01).
Fig. 4. Increased expression of BDNF and GDNF by Pitx3 transfec-
tion in primary VM cultures. Both mRNA levels (left) and protein
levels (right) of BDNF and GDNF were increased in Pitx3-transfected
VM cultures as compared with pcDNA3.1-transfected VM cultures.
1360 C. Peng et al. / FEBS Letters 581 (2007) 1357–1361Pitx3 regulates BDNF and GDNF expression. Furthermore,
the ﬁndings in vitro may need further veriﬁcation in Pitx3-over
expressed transgenic mice and in Pitx3-deﬁcient mice to deter-
mine whether BDNF and GDNF expression is altered by Pitx3
in vivo.
Using semiquantitative PCR analyses we showed that
mRNA expression of general DA markers such as Nurr1,
TH, AADC, and DAT were unchanged or only marginally
aﬀected in the Pitx3-expressing SH-SY5Y cells. These results
were consistent with the report of Chung et al., who found
overexpression Pitx3 did not alter expression general DA
markers such as TH and DAT in ﬁnal diﬀerentiation of ES
cells [22]. It has been reported that Nurr1-null mice did not
show TH-expression in E12.5 embryonic midbrain but did
have Pitx3-expressing neurons in E11.5 embryonic midbrain
[23]. Pitx3-deﬁcient mice scarcely changed the TH expression
pattern in E11.5 embryonic midbrain [5]. These results indicate
that Pitx3 and Nurr1 independently control two aspects of
speciﬁcation of DA neurons in the development of the mid-
brain.
In conclusion, our study demonstrated that Pitx3 upregu-
lated the mRNA and protein expressions of BDNF and
GDNF in vitro, and elevated the release of BDNF and GDNF
to the culture medium. Our ﬁndings shed new light on our
understanding of the gene regulation and molecular pathway
of Pitx3 acting on the survival of midbrain DA neurons, and
suggest that Pitx3 might be a potential new drug target for
the treatment of Parkinson’s disease.Acknowledgements: This work was supported by a Research Fund
(05DJ14007) from Science and Technology Commission of Shanghai
Municipality, and a Research Fund (E03003) from High Education
Commission of Shanghai Municipality.References
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